• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Bangalore, July 4

Strides Arcolab Ltd on Tuesday said WHO has approved its fifth HIV drug product. Three more have been submitted for pre-qualification. WHO has included Lamivudine/Zidovidine developed by Strides in its list of pre-qualified suppliers. This is the generic fixed dose combination for anti-HIV treatment.

More Stories on : Standards & Benchmarks | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Merc puts E class variant on hold

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line